or Try an Advanced Search...

    Technical Analysis for EPRX - Eupraxia Pharmaceuticals Inc.

    Grade Last Price % Change Price Change
    D 2.68 -2.19% -0.06
    EPRX closed down 2.19 percent on Wednesday, May 1, 2024, on 28 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    Earnings due: May 9
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A N/A Down
    Historical EPRX trend table...
    Date Alert Name Type % Chg
    Hot IPO Pullback Bullish Swing Setup 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Gapped Down Weakness 0.00%
    Hot IPO Pullback Bullish Swing Setup -2.19%
    Narrow Range Bar Range Contraction -2.19%
    Hot IPO Pullback Bullish Swing Setup -0.74%
    Down 3 Days in a Row Weakness -0.74%
    Down 4 Days in a Row Weakness -0.74%
    Older End-of-Day Signals for EPRX ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 10 hours ago
    Possible Inside Day about 10 hours ago
    Down 2 % about 11 hours ago
    Down 1% about 11 hours ago
    Possible NR7 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    EPRX Chart by TradingView
    Basic chart:

    Profile

    Eupraxia Pharmaceuticals, Inc. operates as a drug delivery technology company in Canada. It delivers drugs into body compartments, such as the joint without any of the common issues with body compartment injections, such as systemic exposure. The firm focuses on arthritis, diabetic macular edema, and chronic pain programs. The company was founded by James A. Helliwell and John Salvatore Montalbano on May 12, 2011 and is headquartered in Victoria, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Chronic Pain Chronic Condition Diabetic Retinopathy Macular Edema Arthritis Diabetic Macular Edema Drug Delivery Technology Medical Signs

    Is EPRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 11 Eupraxia Pharmaceuticals Announces Upcoming Presentations at the Osteoarthritis Research Society International World Congress 2024
    Apr 8 Eupraxia Pharmaceuticals To Present at Bloom Burton & Co. Healthcare Investor Conference
    Apr 1 Eupraxia Pharmaceuticals  reports Q4 results
    See more EPRX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.55
    52 Week Low 2.48
    Average Volume 17,866
    200-Day Moving Average 0.00
    50-Day Moving Average 0.00
    20-Day Moving Average 0.00
    10-Day Moving Average 2.79
    Average True Range 0.18
    RSI (14) 47.09
    ADX 0.0
    +DI 19.99
    -DI 17.32
    Chandelier Exit (Long, 3 ATRs) 3.00
    Chandelier Exit (Short, 3 ATRs) 3.03
    Upper Bollinger Bands 0.00
    Lower Bollinger Band 0.00
    Percent B (%b) 0.0
    BandWidth 0.00
    MACD Line -0.01
    MACD Signal Line 0.01
    MACD Histogram -0.0184
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.68
    Resistance 3 (R3) 2.68 2.68 2.68
    Resistance 2 (R2) 2.68 2.68 2.68 2.68
    Resistance 1 (R1) 2.68 2.68 2.68 2.68 2.68
    Pivot Point 2.68 2.68 2.68 2.68 2.68
    Support 1 (S1) 2.68 2.68 2.68 2.68 2.68
    Support 2 (S2) 2.68 2.68 2.68 2.68
    Support 3 (S3) 2.68 2.68 2.68
    Support 4 (S4) 2.68